Quality of Life Assessment in Older Patients with Newly-Diagnosed Multiple Myeloma

被引：0
|
作者：
Mian, Hira [1 ]
Fiala, Mark [2 ]
Pond, Gregory [1 ]
Wildes, Tanya [2 ]
机构：
[1] Juravinski Canc Ctr, Hamilton, ON, Canada
[2] Washington Univ, Sch Med, St Louis, MO USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
Elderly; Quality of Life;
D O I：
10.1016/j.clml.2019.09.386
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-060
引用
收藏
页码：E232 / E233
页数：2
相关论文
共 50 条
  • [31] Determining the impact of multimorbidity in older patients initiating treatment for newly-diagnosed multiple myeloma using artificial intelligence/machine learning methods
    Fillmore, Nathanael
    DuMontier, Clark
    Tosi, Hannah
    Zheng, Chunlei
    Corrigan, June
    La, Jennifer
    Yilidrim, Cenk
    Dharne, Mayuri
    Elbers, Danne
    Abel, Gregory
    Edwards, Camille
    Gaziano, J. Michael
    Nhan Do
    Brophy, Mary
    Kim, Dae
    Driver, Jane
    Munshi, Nikhil
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S96 - S97
  • [32] Predictors of diagnosis delay and complications for newly-diagnosed myeloma patients.
    Friese, Christopher R.
    Abel, Gregory A.
    Magazu, Lysa A.
    Neville, Bridget A.
    Richardson, Lisa C.
    Earle, Craig C.
    BLOOD, 2007, 110 (11) : 115A - 116A
  • [33] Independent associations of pain, fatigue, and depression with quality of life in individuals newly-diagnosed with multiple sclerosis
    Alschuler, K.
    Ehde, D.
    Kratz, A.
    Jensen, M.
    JOURNAL OF PAIN, 2017, 18 (04): : S81 - S81
  • [34] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    BLOOD CANCER JOURNAL, 2019, 9 (9)
  • [35] Oprozomib in patients with newly diagnosed multiple myeloma
    Parameswaran Hari
    Jeffrey V. Matous
    Peter M. Voorhees
    Kenneth H. Shain
    Mihaela Obreja
    John Frye
    Hisaki Fujii
    Andrzej J. Jakubowiak
    Davide Rossi
    Pieter Sonneveld
    Blood Cancer Journal, 9
  • [36] Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myeloma
    Li, Ying
    Liu, Junru
    Huang, Beihui
    Chen, Meilan
    Diao, Xiangwen
    Li, Juan
    ONCOTARGET, 2017, 8 (15) : 25637 - 25649
  • [37] RENAL-FUNCTION IN NEWLY-DIAGNOSED MULTIPLE-MYELOMA - A DEMOGRAPHIC-STUDY OF 1353 PATIENTS
    KNUDSEN, LM
    HIPPE, E
    HJORTH, M
    HOLMBERG, E
    WESTIN, J
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1994, 53 (04) : 207 - 212
  • [38] Maximal response to infusional chemotherapy prior to autotransplantation influences outcome of patients with newly-diagnosed multiple myeloma
    Sirohi, B
    Powles, R
    Kulkarni, S
    Chau, I
    Saso, R
    Lal, R
    Riggs, A
    Horton, C
    Treleaven, J
    BONE MARROW TRANSPLANTATION, 2001, 27 : S246 - S246
  • [39] Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma
    Mian, Hira
    Fiala, Mark
    Wildes, Tanya M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (02): : 98 - +
  • [40] ELECTROPHYSIOLOGICAL ASSESSMENT OF VISUAL FUNCTION IN NEWLY-DIAGNOSED IDDM PATIENTS
    UCCIOLI, L
    PARISI, V
    MONTICONE, G
    PARISI, L
    DUROLA, L
    PERNINI, C
    NEUSCHULER, R
    BUCCI, MG
    DIABETOLOGIA, 1995, 38 (07) : 804 - 808
12345